NRIX,Nurix Therapeutics, Inc. | Healthcare

Healthcare

NRIX

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Nurix Therapeutics, Inc.NRIX

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and cell therapies for the treatment of cancer and other diseases.

The company develops NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications.

It is also developing DeTIL-0255, a drug-enhanced investigational cell therapy product that uses NX-0255 ex vivo to enhance tumor infiltrating lymphocytes propagation and phenotypic characteristics.

The company has a strategic collaboration agreement with Gilead Sciences, Inc. to discover, develop, and commercialize a pipeline of protein degradation drugs for patients with cancer and other challenging diseases; and Sanofi S.A. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018.

The company was incorporated in 2009 and is headquartered in San Francisco, California.

Latest News >

Bihar Election October 28 Highlights: 52.24% turnout till 5 PM in 1st phase of assembly polls

Oct 28, 2020

Bihar Election 2020 October 28 Highlights: Polling began Wednesday morning in 71 assembly constituencies of Bihar in the first phase of three-phase elections amid tight security and COVID-19 guidelines in place. Of the total 2,14,84,787 electors eligible to exercise the franchise, 1,12,76,396 are male voters, 1,01,29,101 are female electors and 599 are in the third gender category, according to data provided by the Election Commission. There are 78,691 service electors.A total of 1,066 candidates -- 952 men and 114 women -- are in the fray in the first phase of elections being held in constituencies spread across 16 districts. Guidelines have been issued by the Commission for the safe conduct of the electoral exercise in the midst of the raging COVID-19 pandemic.

Delhi schools to remain closed till further orders: Deputy Chief Minister Manish Sisodia

Oct 28, 2020

According to Unlock 5’ guidelines, states can take a call on reopening schools in phases. Several states have also begun the process of reopening schools.

CIC slams govt, says extremely preposterous that MEITY and NIC have 'no idea how Aarogya Setu was created'

Oct 28, 2020

CIC has also asked National Informatics Centre (NIC) to explain its role in the creation of the app within two months, as the app's website says that it was developed by NIC and Information Technology Ministry.

SpiceJet starts facilitating COVID-19 tests for passengers in India, UAE

Oct 27, 2020

In India, the passengers can visit an ICMR-approved laboratory in Mumbai, Delhi, Kochi, Hyderabad, Kolkata, Chennai, Bengaluru, Jalandhar, Chandigarh, Ahmedabad and Pune to give the samples, the release said.